Cargando…
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
OBJECTIVE: To evaluate the long-term effects of rituximab (RTX) on total and specific immunoglobulins (Igs) in patients with neuromyelitis optica spectrum disorders (NMOSDs). METHODS: Total IgG, IgA, and IgM levels were evaluated in 15 patients with NMOSDs treated with RTX (median follow-up 70 month...
Autores principales: | Marcinnò, Andrea, Marnetto, Fabiana, Valentino, Paola, Martire, Serena, Balbo, Alessia, Drago, Aurora, Leto, Maria, Capobianco, Marco, Panzica, Giancarlo, Bertolotto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148550/ https://www.ncbi.nlm.nih.gov/pubmed/30258855 http://dx.doi.org/10.1212/NXI.0000000000000498 |
Ejemplares similares
-
Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018) -
Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology
por: Granieri, Letizia, et al.
Publicado: (2012) -
Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience
por: Kim, Su-Hyun, et al.
Publicado: (2022) -
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
por: Bruschi, Nicolò, et al.
Publicado: (2023) -
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
por: Valentino, Paola, et al.
Publicado: (2016)